MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 21, 2006; DOI: 10.1124/mol.105.017319


0026-895X/06/6906-1998-2006$20.00
Mol Pharmacol 69:1998-2006, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.105.017319v1
69/6/1998    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beleboni, R. O.
Right arrow Articles by dos Santos, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beleboni, R. O.
Right arrow Articles by dos Santos, W. F.

Neurochemical Characterization of a Neuroprotective Compound from Parawixia bistriata Spider Venom That Inhibits Synaptosomal Uptake of GABA and GlycineFormula

Renê Oliveira Beleboni, Renato Guizzo, Andréia Cristina Karklin Fontana, Andrea Baldocchi Pizzo, Ruither Oliveira Gomes Carolino, Leonardo Gobbo-Neto, Norberto Peporine Lopes, Joaquim Coutinho-Netto, and Wagner Ferreira dos Santos

Department of Biochemistry and Immunology, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil (R.O.B., R.O.G.C., J.C.-N.); Department of Biology, Ribeirão Preto Faculty of Philosophy, Sciences, and Literature, University of São Paulo, São Paulo, Brazil (R.G., A.B.P., W.F.d.S.); Department of Physics and Chemistry, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil (L.G.-N, N.P.L.); Department of Neurobiology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania (A.C.K.F.); and Department of Biotechnology, University of Ribeirão Preto, São Paulo, Brazil (R.O.B.)

The major contribution of this work is the isolation of a neuroprotective compound referred to as 2-amino-5-ureidopentanamide (FrPbAII) (Mr = 174) from Parawixia bistriata spider venom and an investigation of its mode of action. FrPbAII inhibits synaptosomal GABA uptake in a dose-dependent manner and probably does not act on Na+, K+, and Ca2+ channels, GABAB receptors, or {gamma}-aminobutyrate:{alpha}-ketoglutarate aminotransferase enzyme; therefore, it is not directly dependent on these structures for its action. Direct increase of GABA release and reverse transport are also ruled out as mechanisms of FrPbAII activities as well as unspecific actions on pore membrane formation. Moreover, FrPbAII is selective for GABA and glycine transporters, having slight or no effect on monoamines or glutamate transporters. According to our experimental glaucoma data in rat retina, FrPbAII is able to cross the blood-retina barrier and promote effective protection of retinal layers submitted to ischemic conditions. These studies are of relevance by providing a better understanding of neurochemical mechanisms involved in brain function and for possible development of new neuropharmacological and therapeutic tools.


Received August 22, 2005; accepted March 21, 2006

Address correspondence to: Dr. Wagner F. dos Santos, Department of Biology, Faculty of Philosophy, Sciences, and Literature, University of São Paulo, Av. Bandeirantes, 3900-Ribeirão Preto, São Paulo, Brazil, 14040-901. E-mail: wagnerf{at}usp.br




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. C. K. Fontana, R. de Oliveira Beleboni, M. W. Wojewodzic, W. F. d. Santos, J. Coutinho-Netto, N. J. Grutle, S. D. Watts, N. C. Danbolt, and S. G. Amara
Enhancing Glutamate Transport: Mechanism of Action of Parawixin1, a Neuroprotective Compound from Parawixia bistriata Spider Venom
Mol. Pharmacol., November 1, 2007; 72(5): 1228 - 1237.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics